| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 7.12B | 8.12B | 7.01B | 7.63B | 8.67B | 8.53B |
| Gross Profit | 3.45B | 3.92B | 3.37B | 4.03B | 4.60B | 4.23B |
| EBITDA | 579.28M | 748.35M | 1.22B | 1.20B | 1.12B | 1.06B |
| Net Income | 136.24M | -209.22M | 804.88M | 608.19M | 1.85B | -4.50B |
Balance Sheet | ||||||
| Total Assets | 23.20B | 22.95B | 23.19B | 22.73B | 23.30B | 21.32B |
| Cash, Cash Equivalents and Short-Term Investments | 7.05B | 7.62B | 6.28B | 7.51B | 7.21B | 6.26B |
| Total Debt | 206.47M | 166.21M | 238.10M | 617.98M | 1.45B | 1.33B |
| Total Liabilities | 4.04B | 4.57B | 4.16B | 4.78B | 6.11B | 6.22B |
| Stockholders Equity | 19.16B | 18.37B | 19.02B | 17.96B | 17.19B | 15.09B |
Cash Flow | ||||||
| Free Cash Flow | 667.33M | 2.41B | 954.13M | 1.25B | 879.35M | 821.95M |
| Operating Cash Flow | 840.47M | 2.53B | 1.13B | 1.58B | 1.12B | 1.11B |
| Investing Cash Flow | -1.26B | -1.76B | -3.39B | 528.10M | 936.23M | -4.19B |
| Financing Cash Flow | -471.75M | -346.01M | -510.82M | -1.15B | -349.99M | -92.34M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
66 Neutral | HK$36.37B | 37.13 | 19.44% | 2.92% | 15.57% | 94.36% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
60 Neutral | HK$21.68B | 13.17 | 6.05% | 9.97% | -5.74% | -14.46% | |
60 Neutral | HK$20.49B | 6.22 | 12.49% | 8.13% | -1.40% | 22.37% | |
53 Neutral | HK$2.35B | 21.72 | 2.39% | ― | -23.80% | ― | |
52 Neutral | HK$36.08B | 250.14 | 0.67% | ― | -10.26% | -85.75% | |
49 Neutral | HK$8.12B | 99.01 | 0.82% | 4.71% | -7.61% | -90.51% |
China Literature Limited has scheduled a board meeting for March 17, 2026 to review and approve the annual results of the company and its subsidiaries for the financial year ending December 31, 2025, and to consider the publication of these results and the potential declaration of a final dividend. The announcement signals an upcoming key financial disclosure and possible shareholder return decision, which will be closely watched by investors for insight into the company’s operational performance and capital allocation strategy in the competitive online literature sector.
The most recent analyst rating on (HK:0772) stock is a Hold with a HK$36.00 price target. To see the full list of analyst forecasts on China Literature stock, see the HK:0772 Stock Forecast page.
China Literature Limited has announced the renewal of its existing cooperation agreement with Tencent Computer, extending their collaboration on novel creation and competition organization through the 2026 Novel Creation and Solicitation Cooperation Framework Agreement. Additionally, the company has entered into new agreements with YHKT for IP and merchandise cooperation and joint investment in media products. These transactions are considered continuing connected transactions under the Hong Kong Stock Exchange Listing Rules, requiring reporting and annual review but exempt from independent shareholders’ approval.
The most recent analyst rating on (HK:0772) stock is a Hold with a HK$36.00 price target. To see the full list of analyst forecasts on China Literature stock, see the HK:0772 Stock Forecast page.
China Literature Limited has announced a voluntary on-market share buy-back plan, approved by its board of directors. The plan allows for the repurchase of up to 10% of the company’s issued shares, with a maximum fund allocation of HKD1.2 billion, using existing cash reserves. The board believes the shares are undervalued and aims to reflect confidence in the company’s prospects while maintaining financial resources for growth.
The most recent analyst rating on (HK:0772) stock is a Hold with a HK$36.00 price target. To see the full list of analyst forecasts on China Literature stock, see the HK:0772 Stock Forecast page.
China Literature Limited has updated the terms of reference for its Nomination Committee, which is responsible for identifying and recommending director candidates, overseeing board performance evaluations, and developing nomination guidelines. The committee’s composition requires a majority of independent non-executive directors and includes provisions for gender diversity, reflecting the company’s commitment to governance and diversity.
The most recent analyst rating on (HK:0772) stock is a Hold with a HK$36.00 price target. To see the full list of analyst forecasts on China Literature stock, see the HK:0772 Stock Forecast page.